Shailender Bhatia

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with University of Washington, Fred Hutch Cancer Center

MedicineEnvironmental ScienceImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma”.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478

N/A

4.0DataRank · unranked

140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

The relationship between circulating tumor DNA with Merkel cell carcinoma tumor burden and detection of recurrence.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9566

N/A

0.814DataRank · unranked

11 citations

Naomi So, Daniel S. Hippe, Lindsay Gunnell, Coley Doolittle‐Amieva, Kristina Lachance +11 more

Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications

Journal of Clinical Oncology(2024)10.1200/jco.23.02054

N/A

0.505DataRank · unranked

28 citations

Manisha Thakuria, Ann W. Silk, Daniel S. Hippe, Song Y. Park, Naomi So +19 more

Extended duration of anti-PD-1 therapy, using reduced frequency dosing, in patients with advanced melanoma and Merkel cell carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2588

N/A

0.269DataRank · unranked

5 citations

Karly Williams Silva, Daniel S. Hippe, Dane Fritzsche, Aleksandra Raczka, Andrea Perdue +8 more

Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management

Journal of the American Academy of Dermatology(2025)10.1016/j.jaad.2025.10.032

N/A

0.269DataRank · unranked

5 citations

Manisha Thakuria, Ann W. Silk, Daniel S. Hippe, Peter Ch’en, Song Youn Park +18 more

Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function

Cancer Cell(2022)10.1016/j.ccell.2022.03.006

N/A

0DataRank · unranked

146 citations

Sylvia M. Lee, Carolyn Shasha, Naina Singhi, Julia Szeto, Ata S. Moshiri +17 more

Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review

Cancers(2022)10.3390/cancers14235914

N/A

0DataRank · unranked

9 citations

Kelsey Cahill, Gensuke Akaike, E.T. Huynh, Daniel S. Hippe, Michi M. Shinohara +9 more

Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot study

Supportive Care in Cancer(2022)10.1007/s00520-022-06825-w

N/A

0DataRank · unranked

8 citations

Ulrike Peters, Nathaniel F. Watson, Scott S. Tykodi, Evan Hall, Allison Silverman +9 more

Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004839

N/A

0DataRank · unranked

15 citations

Aparna Nallagangula, Jacob Choi, Lisa Tachiki, Matthew Blackburn, Stephen Capone +13 more

Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma

Journal of the American Academy of Dermatology(2023)10.1016/j.jaad.2023.07.1047

N/A

0DataRank · unranked

16 citations

Stephanie K. Schaub, Peter H. Goff, Daniel S. Hippe, Song Y. Park, Kristina Lachance +8 more

Data from Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

(2023)10.1158/1078-0432.c.6528642

N/A

0DataRank · unranked

0 citations

Natalie V. Longino, Natalie J. Miller, Rima M. Kulikauskas, Jayasri G. Iyer, Dafina Ibrani +12 more

Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009803

N/A

0DataRank · unranked

13 citations

Saumya Jani, Peter H. Goff, Rashmi Bhakuni, Shira Tabachnick‐Cherny, Kimberly S. Smythe +8 more

Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma

British Journal of Dermatology(2024)10.1093/bjd/ljae401

N/A

0DataRank · unranked

7 citations

Karam Ashouri, Eftychia Chatziioannou, Jesús Antonio Ocejo Gallegos, Jabra Zarka, Jacob Kechter +39 more

Prognosis of Merkel cell carcinoma patients with autoimmune disorders, other types of immune dysfunction, or immunocompetent status: Analysis of 762 patients

Journal of the American Academy of Dermatology(2024)10.1016/j.jaad.2023.12.039

N/A

0DataRank · unranked

2 citations

Daniel S. Hippe, Lauren Zawacki, Marika Bierma, Shailender Bhatia, Paul Nghiem +3 more

A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer

ESMO Open(2025)10.1016/j.esmoop.2025.104536

N/A

0DataRank · unranked

60 citations

Martin H. Voss, Hussein A. Tawbi, Michael S. Gordon, Scott S. Tykodi, Elaine T. Lam +13 more

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

Journal of the American Academy of Dermatology(2025)10.1016/j.jaad.2025.03.006

N/A

0DataRank · unranked

8 citations

Song Y. Park, Shailender Bhatia, Daniel S. Hippe, Paul Nghiem, Kelly G. Paulson

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2020)10.1016/j.ccell.2020.08.005

N/A

0DataRank · unranked

389 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo +31 more

Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013564

N/A

0DataRank · unranked

2 citations

Smitha Chandrasekhar, Ted Gooley, Rita E. Chen, Coley Doolittle‐Amieva, George Ansstas +6 more

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000331

N/A

0DataRank · unranked

125 citations

Kristina Navrazhina, Fei Ding, Roma Bhatia, Katy K. Tsai, Kelly Abbate +23 more

Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0647

N/A

0DataRank · unranked

37 citations

Mariliis Ott, Candice D. Church, Rima M. Kulikauskas, Dafina Ibrani, Jayasri G. Iyer +11 more

Postoperative, Single-Fraction Radiation Therapy in Merkel Cell Carcinoma of the Head and Neck

Advances in Radiation Oncology(2020)10.1016/j.adro.2020.07.003

N/A

0DataRank · unranked

28 citations

Stephanie K. Schaub, Peter H. Goff, Alex Z. Fu, Song Y. Park, Daniel S. Hippe +7 more

Predictive Lifestyle Markers for Efficacy of Cancer Immune Checkpoint Inhibitors: A Commentary

Future Oncology(2021)10.2217/fon-2020-0730

N/A

0DataRank · unranked

1 citations

Scott S. Tykodi, Evan Hall, John A. Thompson, Nathaniel F. Watson, Sylvia M. Lee +8 more